{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:19:29Z","timestamp":1791425969943,"version":"4.3.3"},"reference-count":53,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.vaccine.2008.03.009","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T12:11:07Z","timestamp":1207051867000},"page":"2762-2771","source":"Crossref","is-referenced-by-count":59,"title":["Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system"],"prefix":"10.1016","volume":"26","author":[{"given":"Douglas G.","family":"Widman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafik","family":"Fayzulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.03.009_bib1","series-title":"Fields\u2019 virology","author":"Fields","year":"2007"},{"key":"10.1016\/j.vaccine.2008.03.009_bib2","unstructured":"CDC. 2007 West Nile Virus Activity in the United States; 2007. Available from: http:\/\/www.cdc.gov\/ncidod\/dvbid\/westnile [cited October 1, 2007]."},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.009_bib3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0042-6822(91)90034-9","article-title":"Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection","volume":"180","author":"Mason","year":"1991","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.009_bib4","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/JVI.67.3.1672-1675.1993","article-title":"Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein","volume":"67","author":"Konishi","year":"1993","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.009_bib5","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/JVI.75.5.2204-2212.2001","article-title":"Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles","volume":"75","author":"Konishi","year":"2001","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.009_bib6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0042-6822(92)90526-U","article-title":"Mice immunized with a subviral particle containing the Japanese encephalitis virus prM\/M and E proteins are protected from lethal JEV infection","volume":"188","author":"Konishi","year":"1992","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2008.03.009_bib7","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1086\/425933","article-title":"Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells","volume":"190","author":"Qiao","year":"2004","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.009_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(96)00180-6","article-title":"Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice","volume":"15","author":"Konishi","year":"1997","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2008.03.009_bib9","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0264-410X(01)00446-7","article-title":"Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine","volume":"20","author":"Konishi","year":"2002","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2008.03.009_bib10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0264-410X(99)00376-X","article-title":"A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice","volume":"18","author":"Konishi","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.009_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/viro.1999.0142","article-title":"Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine","volume":"268","author":"Konishi","year":"2000","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2008.03.009_bib12","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.4049\/jimmunol.163.12.6756","article-title":"A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms","volume":"163","author":"Aberle","year":"1999","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.03.009_bib13","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1073\/pnas.0307145101","article-title":"Mimicking live flavivirus immunization with a noninfectious RNA vaccine","volume":"101","author":"Kofler","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.009_bib14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1006\/viro.1995.1516","article-title":"Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection","volume":"212","author":"Pugachev","year":"1995","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.009_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/viro.1996.8331","article-title":"Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice","volume":"227","author":"Konishi","year":"1997","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.009_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0264-410X(94)90206-2","article-title":"Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice","volume":"12","author":"Fonseca","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.009_bib17","first-page":"221","article-title":"Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","volume":"18","author":"Minke","year":"2004","journal-title":"Arch Virol Suppl"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2008.03.009_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0264-410X(00)00191-2","article-title":"Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans","volume":"19","author":"Kanesa-thasan","year":"2000","journal-title":"Vaccine"},{"issue":"15 (April 12)","key":"10.1016\/j.vaccine.2008.03.009_bib19","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.vaccine.2006.12.015","article-title":"17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics Marseille, France, Monday 12 September 2005","volume":"25","author":"Barrett","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.03.009_bib20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.SMJ.0000157537.11806.DC","article-title":"Rare case of fatal yellow fever vaccine-associated viscerotropic disease","volume":"98","author":"Gerasimon","year":"2005","journal-title":"South Med J"},{"issue":"9","key":"10.1016\/j.vaccine.2008.03.009_bib21","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1128\/JVI.76.9.4162-4171.2002","article-title":"Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response","volume":"76","author":"Su","year":"2002","journal-title":"J Virol"},{"issue":"50","key":"10.1016\/j.vaccine.2008.03.009_bib22","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2008.03.009_bib23","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","volume":"17","author":"Monath","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.009_bib24","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"22","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.03.009_bib25","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.009_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0042-6822(03)00450-1","article-title":"Molecularly engineered live-attenuated chimeric West Nile\/dengue virus vaccines protect rhesus monkeys from West Nile virus","volume":"314","author":"Pletnev","year":"2003","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.009_bib27","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","article-title":"West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy","volume":"99","author":"Pletnev","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"40\u201341","key":"10.1016\/j.vaccine.2008.03.009_bib28","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1016\/j.vaccine.2006.06.008","article-title":"Chimeric West Nile\/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity","volume":"24","author":"Pletnev","year":"2006","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2008.03.009_bib29","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"RR-1","key":"10.1016\/j.vaccine.2008.03.009_bib30","first-page":"1","article-title":"Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"42","author":"CDC","year":"1993","journal-title":"MMWR Recomm Rep"},{"issue":"2 (December)","key":"10.1016\/j.vaccine.2008.03.009_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2222\/jsv.55.303","article-title":"Background of recent JE vaccine issues","volume":"55","author":"Okabe N","year":"2005","journal-title":"Uirusu"},{"issue":"28","key":"10.1016\/j.vaccine.2008.03.009_bib32","first-page":"242","article-title":"Global Advisory Committee on Vaccine Safety, June 9\u201310, 2005","volume":"80","author":"WHO","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"issue":"24","key":"10.1016\/j.vaccine.2008.03.009_bib33","doi-asserted-by":"crossref","first-page":"15107","DOI":"10.1128\/JVI.79.24.15107-15113.2005","article-title":"Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus","volume":"79","author":"Aberle","year":"2005","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.009_bib34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.virol.2006.04.003","article-title":"Production and characterization of vaccines based on flaviviruses defective in replication","volume":"351","author":"Mason","year":"2006","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.vaccine.2008.03.009_bib35","doi-asserted-by":"crossref","first-page":"11737","DOI":"10.1128\/JVI.01112-07","article-title":"Production of pseudoinfectious yellow fever virus with a two-component genome","volume":"81","author":"Shustov","year":"2007","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.03.009_bib36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3201\/eid0704.017420","article-title":"West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis","volume":"7","author":"Xiao","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.009_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.virol.2004.10.046","article-title":"Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action","volume":"331","author":"Rossi","year":"2005","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.009_bib38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2006.02.036","article-title":"Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines","volume":"351","author":"Fayzulin","year":"2006","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2008.03.009_bib39","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1128\/JVI.79.12.7597-7608.2005","article-title":"Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells","volume":"79","author":"Petrakova","year":"2005","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2008.03.009_bib40","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.vaccine.2008.03.010","article-title":"Construction and evaluation of a chimeric pseudovirus vaccine to prevent Japanese encephalitis","volume":"26","author":"Ishikawa","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.009_bib41","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.74.4.1742-1751.2000","article-title":"Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose\u2013response effectiveness and extended safety testing in rhesus monkeys","volume":"4","author":"Monath","year":"2000","journal-title":"J Virol"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2008.03.009_bib42","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","article-title":"Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.009_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4161\/hv.2.4.2944","article-title":"The live attenuated dengue serotype 1 vaccine rDEN1Delta30 is safe and highly immunogenic in healthy adult volunteers","volume":"4","author":"Durbin","year":"2006","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.009_bib44","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"12","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2008.03.009_bib45","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.vaccine.2006.08.008","article-title":"Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis","volume":"25","author":"Watts","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.009_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0042-6822(91)90788-D","article-title":"Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus","volume":"185","author":"Konishi","year":"1991","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.009_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/viro.1993.1006","article-title":"Regulation of the late events in flavivirus protein processing and maturation","volume":"192","author":"Yamshchikov","year":"1993","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.vaccine.2008.03.009_bib48","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1128\/JVI.73.10.8083-8094.1999","article-title":"Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing","volume":"73","author":"Amberg","year":"1999","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.009_bib49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/JVI.74.1.24-32.2000","article-title":"Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage in vitro is lethal for virus production","volume":"74","author":"Lee","year":"2000","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.009_bib50","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1128\/JVI.78.1.178-186.2004","article-title":"Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes","volume":"78","author":"Lobigs","year":"2004","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.03.009_bib51","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.03.009_bib52","series-title":"Vaccine","first-page":"919","article-title":"Japanese encephalitis vaccine","author":"Halstead","year":"2004"},{"issue":"44 (October 30)","key":"10.1016\/j.vaccine.2008.03.009_bib53","first-page":"337","article-title":"Japanese encephalitis vaccines","volume":"73","author":"WHO","year":"1998","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T11:12:41Z","timestamp":1684321961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08003095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":53,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0264410X08003095"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}